Cargando…

P34.01 6-Weekly vs 3-Weekly Pembrolizumab – Toxicities and Tolerance in The COVID-era

Detalles Bibliográficos
Autores principales:	Douglas, C., Lord, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523141/ http://dx.doi.org/10.1016/j.jtho.2021.08.418

Ejemplares similares

P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK
por: Aujayeb, A.
Publicado: (2021)

P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer
por: Dubé-Pelletier, Maude, et al.
Publicado: (2023)

P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution
por: Teixeira, C.H., et al.
Publicado: (2021)

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021)

P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient
por: Aujayeb, A.
Publicado: (2021)

P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre
por: Petersen, L., et al.
Publicado: (2021)

P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
por: Tsukazan, M.T., et al.
Publicado: (2021)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study
por: Ospina Serrano, A.V., et al.
Publicado: (2021)

P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study
por: Patel, A., et al.
Publicado: (2021)

P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
por: Araujo, A., et al.
Publicado: (2021)

EP06.01-007 Fate of Pneumonectomy Patients During Covid-19 Pandemic
por: Güler, G., et al.
Publicado: (2022)

EP06.01-014 Lung Resections After COVID: Short-term Outcomes
por: Kodaganur Gopinath, S., et al.
Publicado: (2022)

EP06.01-003 Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
por: Samnani, S., et al.
Publicado: (2022)

EP06.01-009 Maintaining Thoracic Services During COVID-19 - A Single Centre Experience
por: Walji, H.D., et al.
Publicado: (2022)

EP06.01-016 Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
por: Laisaar, T., et al.
Publicado: (2022)

EP06.01-006 Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis
por: Ramella, S., et al.
Publicado: (2022)

EP06.01-004 Lung Cancer Resection During the Covid-19 Pandemic: A Single Centre Study
por: Oyebanji, T.N., et al.
Publicado: (2022)

EP06.01-002 Cancer Care in a Time of COVID: Lung Cancer Patient’s Experience of Telehealth and Connectedness.
por: Fraser, A.
Publicado: (2022)

EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
por: Garitaonaindía Díaz, Y., et al.
Publicado: (2022)

EP06.01-012 Impact of COVID-19 on the Stage of Lung Cancer Diagnosis at the Mohamed VI Center for Cancer Treatment in Morocco
por: Panandtigri, S., et al.
Publicado: (2022)

EP06.01-005 COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center
por: Mondal, D., et al.
Publicado: (2022)

EP06.01-013 Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Year: Our Clinical Experience
por: crvenkova, s., et al.
Publicado: (2022)

EP06.01-015 Will Virtual Care Stand the Test of Time; One Site’s Perspective on the Continuity of Virtual Care Post-Pandemic
por: Lee, S., et al.
Publicado: (2022)

EP06.01-008 COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
por: Sheeka, A., et al.
Publicado: (2022)

EP06.01-011 COVID-19 Impact in Thoracic Surgery: a Comparison Between Public and Private Care in a Single-Center Facility
por: Casanova Schulze, P.A., et al.
Publicado: (2022)

EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
por: Rizzolo, A., et al.
Publicado: (2022)

EP06.01-010 Clinical Outcomes after Hypo Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer During The Covid-19 Pandemic In Morocco
por: cherkaoui, M., et al.
Publicado: (2022)

FP06.03 COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic?
por: Tsukazan, M.T., et al.
Publicado: (2021)

FP06.02 The Impact of The COVID-19 Pandemic on New Diagnoses of Lung Cancer: A 3-Year Review of an Irish Cancer Centre
por: Carroll, H., et al.
Publicado: (2021)

Letter to editor: brain awareness week, CoVID-19 infection and neurological sciences
por: Mosaferchi, Saeedeh, et al.
Publicado: (2020)

Single-Center Vascular Hub Experience after 7 weeks of COVID-19 Pandemic in Lombardy (Italy)
por: Mascia, Daniele, et al.
Publicado: (2020)

Identifying COVID-19 clusters in Tennessee long-term care facilities based on weekly staff vaccination rates
por: Turner, Marissa, et al.
Publicado: (2023)

Excess mortality from COVID-19: weekly excess death rates by age and sex for Sweden and its most affected region
por: Modig, Karin, et al.
Publicado: (2020)

COVID-19 and Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis: a Case Report
por: Ramos-Ruperto, Luis, et al.
Publicado: (2021)

Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study
por: Loveday, Chey, et al.
Publicado: (2021)

Preventing the Spread: A Comprehensive Cancer Center’s Journey to Prevent the Spread of Coronavirus Disease (Covid-19) During the 2020 Pandemic
por: Carraway, Stephanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mjgde1puqg79g616as5rbpjp64